NIKE, Inc. (NYSE: NKE), Walt Disney (NYSE: DIS), OMNOVA Solutions Inc. (NYSE: OMN), Onyx Pharmaceuticals, Inc. (NASDAQ: ONXX), Charles River Laboratories (NYSE: CRL) and Cytokinetics, Inc. (NASDAQ: CYTK) had ratings on them reiterated by analysts.
Sterne Agee reiterated its "Buy” rating on NIKE, Inc. (NKE). They have a price target of $110.00 on the company.
Morgan Stanley (NYSE:MS) reiterated its "Overweight” rating on Walt Disney (DIS). They have a price target of $44.00 on the company.
Jefferies (NYSE:JEF) reiterated its "Buy” rating on OMNOVA Solutions Inc. (OMN). They have a price target of $6.00 on the company.
Brean Murray reiterated its "Hold” rating on Onyx Pharmaceuticals, Inc. (ONXX).
Deutsche Bank (NYSE:DB) reiterated its "Hold” rating on Charles River Laboratories (CRL).
Canaccord Genuity reiterated its "Buy” rating on Cytokinetics, Inc. (CYTK).
Thursday, December 15, 2011
NIKE (NKE) (DIS) (OMN) (ONXX) (CRL) (CYTK) Ratings Reiterated
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment